Drug Shortage Report for NASONEX
| Report ID | 224304 |
| Drug Identification Number | 02238465 |
| Brand name | NASONEX |
| Common or Proper name | mometasone furoate monohydrate aqueous nasal spray |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 140dose |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-04 |
| Estimated end date | 2024-05-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-04-05 | English | Compare |
| v3 | 2024-04-04 | French | Compare |
| v2 | 2024-04-04 | English | Compare |
| v1 | 2024-04-04 | English | Compare |
Showing 1 to 4 of 4